glp-1 and bipolar Glucagon-like peptide-1 medicines in neurological psychiatric disorders: Cell Reports Medicine An analysis on the role

This change moves eating from a compulsive, reward-driven behavior back to a purely physiological need

The muscle loss reduces venous pump function, and the lack of movement allows blood to pool

Donnelly, D

The disadvantage is the metabolic disruption of stopping and starting, which may reduce the efficiency of subsequent treatment courses

GLP-1R agonists have been shown to lower blood glucose, inhibit food intake and substantially reduce body weight 2

In the present work, we studied the applicability of SURFASA score in a retrospective cohort of children with severe autoimmune hepatitis to predict steroid response